Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Jan 13;25(1):48.
doi: 10.1186/s13063-024-07924-1.

Efficacy and safety of early YAG laser vitreolysis for symptomatic vitreous floaters: the study protocol for a randomized clinical trial

Zhou Hangshuai  1 , Jin Yanhua  2 , Zhou Yao  2 , Zhao Guangjin  2 , Wu Hongyan  2 , Chen Fanlian  2
Affiliations

Efficacy and safety of early YAG laser vitreolysis for symptomatic vitreous floaters: the study protocol for a randomized clinical trial

Zhou Hangshuai et al. Trials. .

Abstract

Background: Vitreous floaters are a common ocular condition that affects individuals of all ages. Although vitreous floaters are typically benign, they can significantly impair visual acuity and quality of life. Laser vitreolysis, which uses an Nd: YAG laser to vaporize collagenous vitreous opacities, is increasingly being used as a treatment option. However, there is currently a lack of evidence regarding its efficacy and the appropriate timing of its application. This study aims to evaluate the efficacy and safety of early intervention with YAG laser vitreolysis in treating symptomatic vitreous floaters.

Methods: The present study is a randomized, controlled, double-blind clinical trial. A total of 70 participants with symptomatic floaters for 1 month were prospectively recruited. These participants will be randomly assigned to two groups, with 35 individuals in each group: the early treatment group and the delayed treatment group. Participants assigned to the early treatment group will undergo YAG laser vitreolysis immediately, followed by a sham laser treatment 3 months later. On the other hand, participants assigned to the delayed treatment group will receive a sham laser treatment and then undergo YAG laser vitreolysis 3 months later. The follow-up time points will be 1, 3, 6, and 12 months from randomization. Primary outcomes will be participants' self-reported improvement in visual disturbance on a scale of 1 to 10 and their scores on the National Eye Institute Visual Functioning Questionnaire 25 (NEI VFQ-25). Secondary outcomes will be an objective evaluation of the effectiveness of the treatment in reducing vitreous floaters through OCT and fundus photography and tracking any adverse events related to the eyes or overall health.

Discussion: This clinical trial aims to evaluate the effectiveness of YAG laser vitreolysis in treating symptomatic vitreous floaters and assess the safety of performing early intervention with YAG laser vitreolysis.

Trial registration: ClinicalTrials.gov NCT05800353 . Registered on 10 March 2023.

Keywords: Nd: YAG laser; Vitreolysis; Vitreous floaters.

PubMed Disclaimer

Conflict of interest statement

The authors declare that they have no competing interests.

Figures

Fig. 1
Fig. 1
Standardized Protocol Items: Recommendations for Interventional Trials (SPIRIT)
Fig. 2
Fig. 2
Flow of participants
See this image and copyright information in PMC

Similar articles

See all similar articles

References

    1. Sebag J. Floaters and the quality of life. Am J Ophthalmol. 2011;152(1):3–4 e1. doi: 10.1016/j.ajo.2011.02.015. - DOI - PubMed
    1. Milston R, Madigan MC, Sebag J. Vitreous floaters: etiology, diagnostics, and management. Surv Ophthalmol. 2016;61(2):211–227. doi: 10.1016/j.survophthal.2015.11.008. - DOI - PubMed
    1. Webb BF, Webb JR, Schroeder MC, North CS. Prevalence of vitreous floaters in a community sample of smartphone users. Int J Ophthalmol. 2013;6(3):402–405. - PMC - PubMed
    1. Henry CR, Smiddy WE, Flynn HW., Jr Pars plana vitrectomy for vitreous floaters: is there such a thing as minimally invasive vitreoretinal surgery? Retina. 2014;34(6):1043–1045. doi: 10.1097/IAE.0000000000000124. - DOI - PMC - PubMed
    1. García BG, Orduna Magán C, Alvarez-Peregrina C, Villa-Collar C, Sánchez-Tena MÁ. Nd:YAG laser vitreolysis and health-related quality of life in patients with symptomatic vitreous floaters. Eur J Ophthalmol. 2021:11206721211008036. - PubMed

Publication types

Supplementary concepts

Associated data